SCHEMBL26051044

SCHEMBL26051044

Cc1nc(-c2ccccc2)c(C(C)C)o1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK13 O15264 1/20 0.51
▸ MAPK12 P53778 1/20 0.51
▸ MAPK11 Q15759 1/20 0.51
▸ MAPK14 Q16539 1/20 0.51
▸ PTGS2 P35354 2/20 0.45
▸ KMT2A Q03164 3/20 0.44
▸ KDM4E B2RXH2 7/20 0.42
▸ L3MBTL1 Q9Y468 3/20 0.41
▸ GAA P10253 1/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ ALDH1A1 P00352 4/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ NR4A2 P43354 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ POLB P06746 2/20 0.38
▸ PTGS1 P23219 1/20 0.38
▸ RXRA P19793 1/20 0.38
▸ MEN1 O00255 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11996623 0.83 MAPK13 (0.46) MAPK13MAPK12MAPK11MAPK14PTGS2
SCHEMBL10832921 0.82 NR4A2 (0.46) MAPK13MAPK12MAPK11MAPK14PTGS2
SCHEMBL10832926 0.82 MAPK14 (0.45) MAPK13MAPK12MAPK11MAPK14PTGS2
SCHEMBL5214925 0.76 MAPK13 (0.58) MAPK13MAPK12MAPK11MAPK14PTGS2
SCHEMBL2091239 0.75 MAPK13 (0.83) MAPK13MAPK12MAPK11MAPK14PTGS2
SCHEMBL15716348 0.73 MAPK13 (0.54) MAPK13MAPK12MAPK11MAPK14PTGS2
SCHEMBL5538991 0.73 MAPK13 (0.54) MAPK13MAPK12MAPK11MAPK14PTGS2
SCHEMBL31469380 0.73 MAPK13 (0.54) MAPK13MAPK12MAPK11MAPK14PTGS2
SCHEMBL18136485 0.70 KDM4E (0.50) MAPK13MAPK12MAPK11MAPK14PTGS2
SCHEMBL12270194 0.70 GAA (0.47) KDM4EGAASMN1; SMN2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023164237-A1 COMPOUNDS AND METHODS USEFUL FOR STABILIZING PHENYLALANINE HYDROXYLASE MUTATIONS AGIOS PHARMACEUTICALS, INC. (US) 2023-08-31 — — WO disclosed
WO-2023164233-A1 (4-BENZO[D]OXAZOL-2-YL)-6,7-DIHYDRO-1H-IMIDAZO[4,5-C]PYRIDINE-5(4H)-YL)METHANONE DERIVATIVES AS MUTANT PAH STABILIZERS FOR THE TREATMENT OF PHENYLKETONURIA AGIOS PHARMACEUTICALS, INC. (US) 2023-08-31 — — WO disclosed
Send feedback